Directorate Change

11^th Apr 2016

EKF Diagnostics Holdings plc (AIM: EKF), the point-of-care business, announces that Ron Zwanziger has resigned as a non-executive director with immediate effect.

EKF Diagnostics Holdings plc Julian Baines, CEO	00 44 29 2071 0570 00 44 7788 420 859
Panmure Gordon (UK) Limited Robert Naylor Paul Fincham	00 44 20 7886 2500
Walbrook PR Limited Paul McManus Lianne Cawthorne	00 44 20 7933 8780 or ekf@walbrookpr.com 00 44 7980 541 893 00 44 7584 391 303

Back to Listing

EKF Diagnostics

EKF Diagnostics Holdings plc is a manufacturer and distrbutor of IVD products. It has three core divisions: Point of Care including hemoglobin and HbA1c analyzers; Central Laboratory including the manufacture of enzymes and clinical chemistry; and Molecular Diagnostics which incorporates a unique DNA enrichment technology, PointMan, and a portfolio of molecular testing services.

News & events

What is the difference between standard Viral and Molecular Transport Media?

To support the increase in COVID-19 testing globally, a safe and easy sample collection and transport mechanism is essential. Learn how PrimeStore^® MTM, a novel viral transport media, enables safe molecular testing for multiple pathogens from one sample swab when compared to standard viral transport media.

EKF introduces novel molecular transport media for dual COVID-19 and influenza sampling

Patented PrimeStore^® MTM technology enables safe sample handling and testing for multiple pathogens from one sample swab

EKF opens for live chats at ENDO Online 2020

Patented PrimeStore^® MTM sample collection device deactivates samples for safe sample handling and transport

EKF secures COVID-19 novel sample collection kit manufacturing and supply contracts

Patented PrimeStore^® MTM sample collection device deactivates samples for safe sample handling and transport

EKF & Tosoh Europe N.V. distribution agreement expands HbA1c POC testing reach in Middle East & Africa